Clinical Features and Outcomes of Spinal Tuberculosis in Central China

References

• Tuli SM. Tuberculosis of the spine: a historical review. Clin Orthop Relat Res. 2007;460:29–38. doi:10.1097/BLO.0b013e318065b75e
   PubMed Web of Science ®Google Scholar
• Wang B, Wang Y, Hao D. Current study of medicinal chemistry for treating spinal tuberculosis. Curr Med Chem. 2021;28(25):5201–5212. doi:10.2174/0929867328666201222125225
   Web of Science ®Google Scholar
• Davies PD, Humphries MJ, Byfield SP, et al. Bone and joint tuberculosis. A survey of notifications in England and Wales. J Bone Joint Surg Br. 1984;66(3):326–330. doi:10.1302/0301-620X.66B3.6427232
   PubMedGoogle Scholar
• Moon MS, Moon JL, Moon YW, et al. Pott’s paraplegia in patients with severely deformed dorsal or dorsolumbar spines: treatment and prognosis. Spinal Cord. 2003;41(3):164–171. doi:10.1038/sj.sc.3101366
   Web of Science ®Google Scholar
• Nene A, Bhojraj S. Results of nonsurgical treatment of thoracic spinal tuberculosis in adults. Spine J. 2005;5(1):79–84. doi:10.1016/j.spinee.2004.05.255
   PubMedGoogle Scholar
• Nussbaum ES, Rockswold GL, Bergman TA, Erickson DL, Seljeskog EL. Spinal tuberculosis: a diagnostic and management challenge. J Neurosurg. 1995;83(2):243–247. doi:10.3171/jns.1995.83.2.0243
   PubMed Web of Science ®Google Scholar
• Sun G, Wang Q, Liang Q, et al. Clinical efficacy and safety of ultra-short-course chemotherapy in treatment of spinal tuberculosis after complete debridement: an observational study. J Int Med Res. 2021;49(2):300060520967611. doi:10.1177/0300060520967611
   Web of Science ®Google Scholar
• Merle CS, Fielding K, Sow OB, et al. A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med. 2014;371(17):1588–1598. doi:10.1056/NEJMoa1315817
   PubMed Web of Science ®Google Scholar
• Darbyshire J. Controlled trial of short-course regimens of chemotherapy in the ambulatory treatment of spinal tuberculosis. Results at three years of a study in Korea. Twelfth report of the Medical research council working party on tuberculosis of the spine. J Bone Joint Surg Br. 1993;75(2):240–248. doi:10.1302/0301-620X.75B2.8444944
   Google Scholar
• Nene AM, Patil S, Kathare AP, Nagad P, Nene A, Kapadia F. Six versus 12 months of anti tubercular therapy in patients with biopsy proven spinal tuberculosis: a single center, open labeled, prospective randomized clinical trial-A pilot study. Spine. 2019;44(1):E1–E6. doi:10.1097/BRS.0000000000002811
   Web of Science ®Google Scholar
• Pandita A, Madhuripan N, Pandita S, Hurtado RM. Challenges and controversies in the treatment of spinal tuberculosis. J Clin Tuberc Other Mycobact Dis. 2020;19:100151. doi:10.1016/j.jctube.2020.100151
   Google Scholar
• Luan H, Liu K, Wang Y, et al. Efficacy of anterior debridement and bone grafting with fusion using internal fixation combined with anti-tuberculosis chemotherapy in the treatment of subaxial cervical tuberculosis. BMC Surg. 2022;22(1):150. doi:10.1186/s12893-022-01606-y
   Web of Science ®Google Scholar
• Bai J, Xia Q, Miao J. Combined anteroposterior approaches in lateral position treatment of lumbosacral tuberculous in single-stage. BMC Surg. 2022;22(1):154. doi:10.1186/s12893-022-01612-0
   Web of Science ®Google Scholar
• Du X, Ou Y, Luo W, Jiang G, Qin W, Zhu Y. Evaluation of the efficacy of OLIF combined posterior internal fixation for single-segment lumbar tuberculosis: a single-center retrospective cohort study. BMC Surg. 2022;22(1):54. doi:10.1186/s12893-022-01492-4
   Web of Science ®Google Scholar
• Su SH, Tsai WC, Lin CY, et al. Clinical features and outcomes of spinal tuberculosis in southern Taiwan. J Microbiol Immunol Infect. 2010;43(4):291–300. doi:10.1016/S1684-1182(10)60046-1
   Google Scholar
• Park DW, Sohn JW, Kim EH, et al. Outcome and management of spinal tuberculosis according to the severity of disease: a retrospective study of 137 adult patients at Korean teaching hospitals. Spine. 2007;32(4):E130–135. doi:10.1097/01.brs.0000255216.54085.21
   PubMed Web of Science ®Google Scholar
• Chen WJ, Chen CH, Shih CH. Surgical treatment of tuberculous spondylitis. 50 patients followed for 2–8 years. Acta Orthop Scand. 1995;66(2):137–142. doi:10.3109/17453679508995507
   PubMed Web of Science ®Google Scholar
• Jutte PC, van Loenhout-Rooyackers JH. Routine surgery in addition to chemotherapy for treating spinal tuberculosis. Cochrane Database Syst Rev. 2006;5:CD004532. doi:10.1002/14651858.CD004532.pub2
   Web of Science ®Google Scholar
• Zhang Z, Luo F, Zhou Q, Dai F, Sun D, Xu J. The outcomes of chemotherapy only treatment on mild spinal tuberculosis. J Orthop Surg Res. 2016;11(1):49. doi:10.1186/s13018-016-0385-y
   PubMed Web of Science ®Google Scholar
• Zhang X, Ji J, Liu B. Management of spinal tuberculosis: a systematic review and meta-analysis. J Int Med Res. 2013;41(5):1395–1407. doi:10.1177/0300060513498023
   PubMed Web of Science ®Google Scholar
• Waheed G, Soliman M, Ali AM, Aly MH. Spontaneous spondylodiscitis: review, incidence, management, and clinical outcome in 44 patients. Neurosurg Focus. 2019;46(1):E10. doi:10.3171/2018.10.FOCUS18463
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party on Tuberculosis of the Spine. A controlled trial of six-month and nine-month regimens of chemotherapy in patients undergoing radical surgery for tuberculosis of the spine in Hong Kong. Tenth report of the medical research council working party on tuberculosis of the spine. Tubercle. 1986;67(4):243–259. doi:10.1016/0041-3879(86)90014-0
   Google Scholar
• Shembekar A, Babhulkar S. Chemotherapy for osteoarticular tuberculosis. Clin Orthop Relat Res. 2002;398:20–26. doi:10.1097/00003086-200205000-00004
   Google Scholar
• Sae-Jung S, Wongba N, Leurmprasert K. Predictive factors for neurological deficit in patients with spinal tuberculosis. J Orthop Surg. 2019;27(3):2309499019868813. doi:10.1177/2309499019868813
   Web of Science ®Google Scholar
• Reisener MJ, Pumberger M, Shue J, Girardi FP, Hughes AP. Trends in lumbar spinal fusion-a literature review. J Spine Surg. 2020;6(4):752–761. doi:10.21037/jss-20-492
   Google Scholar
• Bakhsh A. Medical management of spinal tuberculosis: an experience from Pakistan. Spine. 2010;35(16):E787–791. doi:10.1097/BRS.0b013e3181d58c3c
   PubMed Web of Science ®Google Scholar
• Lan X, Xu JZ, Luo F, Liu XM, Ge BF. 脊柱结核术后复发原因分析及再手术疗效观察 [Analysis of postoperative recurrence reason and observation of reoperation outcome for spinal tuberculosis]. Zhongguo Gu Shang. 2013;26(7):536–542. Chinese.
   Google Scholar
• Divya A, Shukla DP, Bahubali VH, et al. Consumption of spine by tuberculosis in the era of directly observed treatment, short-course and genomic diagnosis. Indian J Tuberc. 2021;68(1):73–79. doi:10.1016/j.ijtb.2020.08.017
   Google Scholar
• Lin L, Ke Z, Cheng S. Efficacy and safety of short-term chemotherapy for patients with spinal tuberculosis undergoing surgery in Chinese population: a meta-analysis. J Orthop Surg Res. 2021;16(1):229. doi:10.1186/s13018-021-02375-9
   Web of Science ®Google Scholar
• Joint T. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax. 1998;53(7):536–548.
   Web of Science ®Google Scholar
• Sharma SK, Ryan H, Khaparde S, et al. Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India. Indian J Med Res. 2017;145(4):448–463. doi:10.4103/ijmr.IJMR_1950_16
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Clifton IJ, Collyns TA, Watson JP, Pearson SB. The treatment of spinal tuberculosis: a retrospective study. Int J Tuberc Lung Dis. 2005;9(5):541–544.
   PubMed Web of Science ®Google Scholar
• Khanna K, Sabharwal S. Spinal tuberculosis: a comprehensive review for the modern spine surgeon. Spine J. 2019;19(11):1858–1870. doi:10.1016/j.spinee.2019.05.002
   PubMed Web of Science ®Google Scholar
• Park CS, Lee JY, Choi HY, et al. Gallic acid attenuates blood-spinal cord barrier disruption by inhibiting Jmjd3 expression and activation after spinal cord injury. Neurobiol Dis. 2020;145:105077. doi:10.1016/j.nbd.2020.105077
   Web of Science ®Google Scholar
• Qiao J, Yang L, Feng J, Dai X, Xu F, Xia P. Analysis of efficacy and safety of linezolid-based chemotherapeutic regimens for patients with postoperative multidrug-resistant spinal tuberculosis. Int J Infect Dis. 2022;118:264–269. doi:10.1016/j.ijid.2022.03.020
   PubMed Web of Science ®Google Scholar
• van Loenhout-Rooyackers JH, Verbeek AL, Jutte PC. Chemotherapeutic treatment for spinal tuberculosis. Int J Tuberc Lung Dis. 2002;6(3):259–265.
   PubMed Web of Science ®Google Scholar
• Darbyshire J. Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months’ duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council Working Party on Tuberculosis of the Spine. Int Orthop. 1999;23(2):73–81. doi:10.1007/s002640050311
   Web of Science ®Google Scholar